COVID-19 vaccination in patients with chronic liver disease

G Schinas, E Polyzou, F Mitropetrou, A Pazionis… - Viruses, 2022 - mdpi.com
Vaccination against SARS-CoV-2 has become a central public health issue, primarily for
vulnerable populations such as individuals with Chronic Liver Disease (CLD). Increased …

mRNA COVID-19 vaccine anaphylaxis: epidemiology, risk factors, and evaluation

J Jaggers, AR Wolfson - Current allergy and asthma reports, 2023 - Springer
Abstract Purpose of Review The COVID-19 vaccines have proved essential in our defense
against the COVID-19 pandemic. However, concerns regarding allergic reactions to the …

An update in COVID-19 vaccine reactions in 2023: progress and understanding

KG Blumenthal, M Greenhawt, EJ Phillips… - The Journal of Allergy …, 2023 - Elsevier
It has been 3 years since the coronavirus disease 2019 (COVID-19) pandemic was initially
declared, and 2 years have passed since the first COVID-19 vaccines were introduced …

Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution

R Münter, E Christensen, TL Andresen… - … Therapy Methods & …, 2023 - cell.com
Following the recent approval of both siRNA-and mRNA-based therapeutics, nucleic acid
therapies are considered a game changer in medicine. Their envisioned widespread use for …

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment and …

M Greenhawt, TE Dribin, EM Abrams, M Shaker… - Journal of Allergy and …, 2023 - Elsevier
This guidance updates 2021 GRADE (Grading of Recommendations Assessment,
Development and Evaluation) recommendations regarding immediate allergic reactions …

[HTML][HTML] SARS-CoV-2 and allergy–what have we learned after two and a half years?

K Brockow, R Wang, S Mathes, R Bent, V Faihs… - Allergologie …, 2023 - ncbi.nlm.nih.gov
Background: Coronavirus disease-2019 (COVID-19) has significantly hampered the regular
workflow for allergists and allergy departments. Materials and methods: The purpose of this …

Investigating generation of antibodies against the lipid nanoparticle vector following COVID-19 vaccination with an mRNA vaccine

R Münter, E Sørensen, RB Hasselbalch… - Molecular …, 2023 - ACS Publications
Despite the success of mRNA-based vaccines against infectious diseases (including COVID-
19), safety concerns have been raised relating to the lipid nanoparticles (LNPs) used to …

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

N Kogseder, V Puxkandl, W Hoetzenecker… - Frontiers in …, 2024 - frontiersin.org
Introduction The COVID vaccination program with new types of vaccinations and early
reports of allergic reactions to vaccines led to vaccination hesitancy in patients with …

[HTML][HTML] COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia

S Koesnoe, S Maria, A Widhani, AS Hasibuan… - World Allergy …, 2023 - Elsevier
Background High COVID-19 vaccine coverage is essential. Patients who are considered
high risk for hypersensitivity reactions and have had an allergic reaction to the COVID-19 …

Immune-mediated organ-specific reactions to COVID-19 vaccines: a retrospective descriptive study

C Ruiz-Fernández, R Cuesta, S Martín-López… - Pharmaceuticals, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 caused the global COVID-19 pandemic
and public health crisis, and it led to the rapid development of COVID-19 vaccines, which …